Eli Lilly has positive phase 3 results for its triple agonist retatrutide in type 2 diabetes (T2D) to go with its earlier encouraging data as a weight-loss therapy. The GIP, GLP-1 and glucagon agonist ...
Nagpur: Researchers from Post Graduate Department of Zoology at Nagpur University developed a device that can detect diabetes through breath, eliminating the need for needle-based blood tests. The ...
The kit offers clear guidance, QR-enabled care, and retail-ready sizing to improve access and usability. When a urinary tract ...
Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.
2don MSN
Skin-deep microneedle sensor tracks drug clearance and reveals early kidney and liver dysfunction
Wearable technologies are starting to reshape how people manage health. Continuous glucose monitors that measure blood sugar ...
CareDx shares rose over 8% in extended trading on Wednesday after the precision medicine company said it will divest its Lab Products business to EuroBio Scientific for cash consi ...
Continuous glucose monitoring (CGM) has emerged as a transformative technology within diabetes care, enabling real-time assessment and nuanced understanding ...
CareDx Inc. CDNA has agreed to sell its Lab Products business to EuroBio Scientific for $170 million in cash, marking a ...
I love to cook—which should come as no surprise considering where I work. But while I relish the opportunity to pull together an elaborate meal, the reality is that most weeknights I find myself ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results